A. Ballester

Risk factors for invasive disease among children in Spain.

I. Pereiró, J. Díez-Domingo, Leopoldo Segarra, 2004, The Journal of infection.

A cost benefit analysis of routine varicella vaccination in Spain.

J. Latour, A. Ballester, A. Morant, 1999, Vaccine.

Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.

J. Díez-Domingo, A. Ballester, M. San-Martín, 2004, The Journal of infection.

Pediatric Safety Evaluation of An AS-Adjuvanted H5N1 Prepandemic Candidate Vaccine in Children Aged 3–9 Years: A Phase II Study

M. Garcés-Sánchez, J. Díez-Domingo, A. Ballester, 2008 .

Immunogenicity and Reactogenicity of a Combined Adsorbed Tetanus Toxoid, Low Dose Diphtheria Toxoid, Five Component Acellular Pertussis and Inactivated Polio Vaccine in Six-Year-Old Children

F. Boisnard, J. Díez-Domingo, A. Ballester, 2005, The Pediatric infectious disease journal.

Seroprevalence of Varicella Among Children and Adolescents in Valencia, Spain: Reliability of the Parent’s Reported History and the Medical File for Identification of Potential Candidates for Vaccination

J. Díez-Domingo, A. Ballester, M. San-Martín, 2005, Human vaccines.

Ibuprofen prophylaxis for adverse reactions to diphtheria-tetanus-pertussis vaccination: a randomized trial

J. Díez-Domingo, A. Ballester, J. Baldó, 1998 .